[(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine

C75H143N4O18P — CID 173279902

IUPAC[(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine
SMILESCCCCCCCCCCC[C@H](CC(=O)N[C@H]1[C@H](OC[C@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)C(N)=O)O[C@H](CO)[C@@H](OP(=O)(O)O)[C@@H]1OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)OC(=O)CCCCC.CCN(CC)CC
InChIInChI=1S/C69H128N3O18P.C6H15N/c1-7-13-19-22-25-28-31-34-40-43-54(85-61(76)46-37-16-10-4)49-59(74)71-57(68(70)80)53-84-69-65(72-60(75)50-55(86-62(77)47-38-17-11-5)44-41-35-32-29-26-23-20-14-8-2)67(66(58(52-73)88-69)90-91(81,82)83)89-64(79)51-56(87-63(78)48-39-18-12-6)45-42-36-33-30-27-24-21-15-9-3;1-4-7(5-2)6-3/h54-58,65-67,69,73H,7-53H2,1-6H3,(H2,70,80)(H,71,74)(H,72,75)(H2,81,82,83);4-6H2,1-3H3/t54-,55-,56-,57+,58-,65-,66-,67-,69-;/m1./s1
InChIKeyXIVZYIIBNPUDSW-MOZLOVBESA-N
MW1419.95 g/mol
LogP15.32
Rot. Bonds64

About [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine

[(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine (PubChem CID 173279902) has the molecular formula C75H143N4O18P and a molecular weight of 1419.95 g/mol. Its IUPAC name is [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine.

Molecular Properties

Compound Name[(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine
PubChem CID173279902
Molecular FormulaC75H143N4O18P
Molecular Weight1419.95 g/mol
Exact Mass1419.01
IUPAC Name[(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine
SMILESCCCCCCCCCCC[C@H](CC(=O)N[C@H]1[C@H](OC[C@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)C(N)=O)O[C@H](CO)[C@@H](OP(=O)(O)O)[C@@H]1OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)OC(=O)CCCCC.CCN(CC)CC
InChIInChI=1S/C69H128N3O18P.C6H15N/c1-7-13-19-22-25-28-31-34-40-43-54(85-61(76)46-37-16-10-4)49-59(74)71-57(68(70)80)53-84-69-65(72-60(75)50-55(86-62(77)47-38-17-11-5)44-41-35-32-29-26-23-20-14-8-2)67(66(58(52-73)88-69)90-91(81,82)83)89-64(79)51-56(87-63(78)48-39-18-12-6)45-42-36-33-30-27-24-21-15-9-3;1-4-7(5-2)6-3/h54-58,65-67,69,73H,7-53H2,1-6H3,(H2,70,80)(H,71,74)(H,72,75)(H2,81,82,83);4-6H2,1-3H3/t54-,55-,56-,57+,58-,65-,66-,67-,69-;/m1./s1
InChIKeyXIVZYIIBNPUDSW-MOZLOVBESA-N
XLogP15.32
TPSA315.18 Ų
H-Bond Donors6
H-Bond Acceptors17
Rotatable Bonds64
Heavy Atoms98
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001419.95
LogP ≤ 515.32
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine?
The IUPAC name of [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine (CID 173279902) is [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine.
What is the SMILES notation for [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine?
The canonical SMILES for [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine is CCCCCCCCCCC[C@H](CC(=O)N[C@H]1[C@H](OC[C@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)C(N)=O)O[C@H](CO)[C@@H](OP(=O)(O)O)[C@@H]1OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCC)OC(=O)CCCCC.CCN(CC)CC.
What is the InChIKey of [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine?
The InChIKey is XIVZYIIBNPUDSW-MOZLOVBESA-N. The full InChI is InChI=1S/C69H128N3O18P.C6H15N/c1-7-13-19-22-25-28-31-34-40-43-54(85-61(76)46-37-16-10-4)49-59(74)71-57(68(70)80)53-84-69-65(72-60(75)50-55(86-62(77)47-38-17-11-5)44-41-35-32-29-26-23-20-14-8-2)67(66(58(52-73)88-69)90-91(81,82)83)89-64(79)51-56(87-63(78)48-39-18-12-6)45-42-36-33-30-27-24-21-15-9-3;1-4-7(5-2)6-3/h54-58,65-67,69,73H,7-53H2,1-6H3,(H2,70,80)(H,71,74)(H,72,75)(H2,81,82,83);4-6H2,1-3H3/t54-,55-,56-,57+,58-,65-,66-,67-,69-;/m1./s1.
What are the key properties of [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine?
[(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine has a molecular weight of 1419.95 g/mol, XLogP of 15.32, 64 rotatable bonds, 6 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4R,5S,6R)-2-[(2S)-3-amino-2-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-3-oxopropoxy]-3-[[(3R)-3-hexanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxyoxan-4-yl] (3R)-3-hexanoyloxytetradecanoate;N,N-diethylethanamine is sourced from PubChem (CID 173279902), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).